An Update on Clinical Trials: Is Tumor Angiogenesis Still a Viable Target in Advanced NSCLC?

被引：0

作者：

Wakelee, Heather A. ^{[1
]}

机构：

[1] Stanford Univ, Med Oncol, Stanford, CA 94305 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

CELL LUNG-CANCER; PHASE-III TRIAL; 1ST-LINE THERAPY; DOUBLE-BLIND; BEVACIZUMAB; PLACEBO; MULTICENTER; CISPLATIN;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MS03.04

引用

页码：S94 / S95

页数：2

共 8 条

[1] Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089) [J].

Barlesi, Fabrice ;

Scherpereel, Arnaud ;

Rittmeyer, Achim ;

Pazzola, Antonio ;

Tur, Neus Ferrer ;

Kim, Joo-Hang ;

Ahn, Myung-Ju ;

Aerts, Joachim G. J. V. ;

Gorbunova, Vera ;

Vikstrom, Anders ;

Wong, Elaine K. ;

Perez-Moreno, Pablo ;

Mitchell, Lada ;

Groen, Harry J. M. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (24) :3004-+

[2] Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial [J].

Garon, Edward B. ;

Ciuleanu, Tudor-Eliade ;

Arrieta, Oscar ;

Prabhash, Kumar ;

Syrigos, Konstantinos N. ;

Goksel, Tuncay ;

Park, Keunchil ;

Gorbunova, Vera ;

Dario Kowalyszyn, Ruben ;

Pikiel, Joanna ;

Czyzewicz, Grzegorz ;

Orlov, Sergey V. ;

Lewanski, Conrad R. ;

Thomas, Michael ;

Bidoli, Paolo ;

Dakhil, Shaker ;

Gans, Steven ;

Kim, Joo-Hang ;

Grigorescu, Alexandru ;

Karaseva, Nina ;

Reck, Martin ;

Cappuzzo, Federico ;

Alexandris, Ekaterine ;

Sashegyi, Andreas ;

Yurasov, Sergey ;

Perol, Maurice .

LANCET, 2014, 384 (9944) :665-673

[3] Randomized Phase IIIb Trial Evaluating the Continuation of Bevacizumab Beyond Disease Progression in Patients with Advanced Non-Squamous Non-Small-Cell Lung Cancer after First-Line Treatment with Bevacizumab Plus Platinum-Based Chemotherapy: Treatment Rationale and Protocol Dynamics of the AvaALL (MO22097) Trial [J].

Gridelli, Cesare ;

Bennouna, Jaafar ;

de Castro, Javier ;

Dingemans, Anne-Marie C. ;

Griesinger, Frank ;

Grossi, Francesco ;

Rossi, Antonio ;

Thatcher, Nick ;

Wong, Elaine K. ;

Langer, Corey .

CLINICAL LUNG CANCER, 2011, 12 (06) :407-411

[4] Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL) [J].

Reck, M. ;

von Pawel, J. ;

Zatloukal, P. ;

Ramlau, R. ;

Gorbounova, V. ;

Hirsh, V. ;

Leighl, N. ;

Mezger, J. ;

Archer, V. ;

Moore, N. ;

Manegold, C. .

ANNALS OF ONCOLOGY, 2010, 21 (09) :1804-1809

[5] Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial [J].

Reck, Martin ;

Kaiser, Rolf ;

Mellemgaard, Anders ;

Douillard, Jean-Yves ;

Orlov, Sergey ;

Krzakowski, Maciej ;

von Pawel, Joachim ;

Gottfried, Maya ;

Bondarenko, Igor ;

Liao, Meilin ;

Gann, Claudia-Nanette ;

Barrueco, Jose ;

Gaschler-Markefski, Birgit ;

Novello, Silvia .

LANCET ONCOLOGY, 2014, 15 (02) :143-155

[6] Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer [J].

Sandler, Alan ;

Gray, Robert ;

Perry, Michael C. ;

Brahmer, Julie ;

Schiller, Joan H. ;

Dowlati, Afshin ;

Lilenbaum, Rogerio ;

Johnson, David H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (24) :2542-2550

[7] Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study [J].

Seto, Takashi ;

Kato, Terufumi ;

Nishio, Makoto ;

Goto, Koichi ;

Atagi, Shinji ;

Hosomi, Yukio ;

Yamamoto, Noboru ;

Hida, Toyoaki ;

Maemondo, Makoto ;

Nakagawa, Kazuhiko ;

Nagase, Seisuke ;

Okamoto, Isamu ;

Yamanaka, Takeharu ;

Tajima, Kosei ;

Harada, Ryosuke ;

Fukuoka, Masahiro ;

Yamamoto, Nobuyuki .

LANCET ONCOLOGY, 2014, 15 (11) :1236-1244

[8] BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer [J].

Zhou, Caicun ;

Wu, Yi-Long ;

Chen, Gongyan ;

Liu, Xiaoqing ;

Zhu, Yunzhong ;

Lu, Shun ;

Feng, Jifeng ;

He, Jianxing ;

Han, Baohui ;

Wang, Jie ;

Jiang, Guoliang ;

Hu, Chunhong ;

Zhang, Hao ;

Cheng, Gang ;

Song, Xiangqun ;

Lu, You ;

Pan, Hongming ;

Zheng, Wenjuan ;

Yin, Anny-Yue .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (19) :2197-U108

← 1 →